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Purpose/Objective: The XRAD225Cx is a small animal radiotherapy 
device using a medium energy beam (225 kVp) and small circular 
fields. In addition to the half-value layers and the absolute dose rate, 
the commissioning of this equipment requires relative dose 
measurements such as percentage depth dose (PDD), Output Factor 
(OF) and Tissue Maximum Ratio (TMR). The aim of this study was to 
compare two media and four detectors to determine the optimal 
conditions to perform these relative measurements. 
Materials and Methods: RW3 material is known not to be water-
equivalent at medium energy for absolute dose measurements. To 
evaluate the impact of this medium for relative dose measurements, 
PDDs were obtained in water and RW3 for a 10x10 cm2 field with a 
plane-parallel ionization chamber and EBT2 Gafchromic films. 
Simulated PDDs were generated using a GATE Monte Carlo model of 
the irradiator. To study the influence of the detector, four dosimeters 
(an IBA SFD diode, a PTW PinPoint 31014 microchamber, EBT2 films 
and a PTW-23342 plane-parallel chamber) were compared for OFs, 
PDDs and TMRs in water and/or RW3 depending on the dosimeter 
sealing. Measurements were performed in small fields (20, 15, 10, 8, 5 
and 2.5 mm in diameter). OFs, PDDs, and TMRs were also computed 
with the Monte Carlo model.  
Results: Measured and simulated PDDs were similar in water and RW3. 
Regardless of media and detectors, simulated and measured OFs 
showed no differences down to a diameter beam of 5 mm. For the 
smallest beam (2.5 mm),ionization chambers yielded large 
discrepancies (up to -22%) compared to SFD and EBT2 measurements 
and Monte Carlo simulations. This is due to the size of the sensitive 
volume of chambers compared to beam diameter. For PDDs and TMRs, 
measurement accuracy depends on spatial resolution in depth of the 
detector. Therefore, PinPoint chamber was not used. Plane ionization 
chamber and film measurements were closed to Monte Carlo 
computed results. SFD diode results showed significant discrepancies 
(up to 9%) due to the important variation in the relative energy 
response of the diode at 225 kVp. 
Conclusions: For relative measurements, RW3 can be used instead of 
water at 225 kVp for convenient considerations. For OFs, all studied 
detectors may be used down to a beam diameter of 5 mm. For smaller 
beams, measurements should be performed with the SFD diode or 
Gafchromic films. For PDDs and TMRs, plane ionization chamber can 
be used down to a beam diameter of 5 mm. Gafchromic films are 
suitable whatever the beam diameter.  
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Purpose/Objective: To assess the sensitivity of three different 
commercially available dosimetry systems in detecting treatment 
delivery errors during helical tomotherapy pre-treatment verification. 
Materials and Methods: Three dosimeters 1) MatriXX Evolution (IBA®) 
with OmniPro-ImRT software 2) ArcCheck®(Sun Nuclear®) with SNC 
Patient software 3) EDR-2 film with cheese phantom and RIT software 
were considered. A head and neck helical tomotherapy plan was 
edited to introduce known systematic errors in couch speed, gantry 
speed, gantry start angle, and projection time. The magnitude of each 
introduced error was +2% and +4% relative to the original treatment 
plan. All measurements were performed at the same time to minimize 
day-to-day and phantom setup variations. For each dosimeter the 
measured dose for the original plan was compared to each altered 
plan with a Gamma analysis using 3%/3 mm pass criteria. 
Results: The gamma pass rates are shown in Table 1. In each case an 
introduced error resulted in a decreased gamma pass rate. Results 
were comparable across the three detectors. Sensitivity to couch 
speed, gantry speed, and start gantry angle were similar for each 
detector. All detectors were most sensitive to projection time errors. 
 
Conclusions: All three dosimetry systems were sensitive to each 
introduced error. Additional work is underway to assess the impact of 
these errors on treatment plans and to include systematic/random 
error in MLC and jaw position. This work will also help to establish 
meaningful tolerance levels for quality assurance. 
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Purpose/Objective: To evaluate the accuracy of the dose calculation 
algorithm for the target (bones) and some sensitive structures (lungs, 
eyes, heart, kidneys) in total marrow irradiation (TMI) performed with 
helical tomotherapy (HT). 
Materials and Methods: Thermoluminescent detectors (TLDs) were 
used to measure delivered doses. Dose optimization was performed 
with the HT treatment planning system. Doses were calculated for 
selected points in the target - bones (9 TLDs), in the central lung (11 
TLDs) and in eye, heart, kidney (4 TLDs) in an anthropomorphic 
phantom. The target dose was 12 Gy to the skeletal bone. A dose of 2 
Gy was delivered 6 times. We compared the calculated dose to the 
measured dose. 
Results: For each dosimetric point, the measured value was averaged 
and corrected by the MVCT scan value and converted according to the 
calibration factors. The mean difference between the measured and 
calculated dose for the bone TLDs was 1.2% (with a range of -4.2% to 
+5.0% for individual detectors included in this group), indicating that 
the measured dose was higher than the calculated dose. For the lung-
TLD group of detectors, the corresponding difference was -1.9% 
(range, -9.0% to +7.6%). At 11 points, the measured dose was lower 
than the calculated dose, with the largest differences observed in the 
region located in the kidney (-9.2%) and lungs (-9.0%).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
 
 
